Work

A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e16512

Authors: David Michael Hyman, Michael Sill, Jonathan K Cho, Heather A. Lankes, Richard Piekarz, Martee Leigh Hensley

Institutions: Memorial Sloan Kettering Cancer Center, Gynecologic Oncology Group, University of Hawaii Cancer Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Uterine Myomas and Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603592220

Cites:

Cited by: 1

Related to: 10